A panel of DNA methylation biomarkers for detection and improving diagnostic efficiency of lung cancer
Abstract Lung cancer remains the leading cause of cancer deaths worldwide. Although low-dose spiral computed tomography (LDCT) screening is used for the detection of lung cancer in a high-risk population, false-positive results of LDCT remain a clinical problem. Here, we developed a blood test of a...
Guardado en:
Autores principales: | Bing Wei, Fengxin Wu, Wenqun Xing, Haibo Sun, Chi Yan, Chengzhi Zhao, Dongqing Wang, Xiaobing Chen, Yanli Chen, Mingming Li, Jie Ma |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8541ccf271504b21b2b6ac9441c1c0c9 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Deciphering a TB-related DNA methylation biomarker and constructing a TB diagnostic classifier
por: Mengyuan Lyu, et al.
Publicado: (2022) -
DNA methylation profiles of the brain-derived neurotrophic factor (BDNF) gene as a potent diagnostic biomarker in major depression.
por: Manabu Fuchikami, et al.
Publicado: (2011) -
MGMT gene promoter methylation in humoral tissue as biomarker for lung cancer diagnosis: An update meta‐analysis
por: Bizheng Chen, et al.
Publicado: (2021) -
DNA Methylation and Type 2 Diabetes: Novel Biomarkers for Risk Assessment?
por: Gregory Alexander Raciti, et al.
Publicado: (2021) -
DNA methylation in lung cancer patients: Opening a 'window of life' under precision medicine
por: Runzhang Liang, et al.
Publicado: (2021)